Association of genetic variants from the Wnt signaling pathway with cardiovascular disease in the Saudi Arabian population
This case-control study in a Saudi Arabian population reveals that specific genetic variants within the Wnt signaling pathway genes (APC, AXIN2, DKK4, SFRP3, and LRP6) are associated with cardiovascular disease risk in an age- and gender-dependent manner, while variants in CTNNB1, TCF7L2, and DKK3 showed no significant association.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
The human body relies on a complex network of chemical signals to tell cells when to grow, when to stop, and how to organize themselves into tissues. One of the most important of these signaling systems is known as the Wnt pathway. You can think of this pathway as a master switchboard that controls the development of the heart and blood vessels before a baby is born, and later helps maintain those tissues throughout life. When this system works correctly, it keeps the heart muscle healthy and the blood vessels flexible. However, when the signals go wrong—either by staying stuck in the "on" position or failing to activate when needed—it can lead to serious problems, including the hardening of arteries and heart failure. While doctors have long known that lifestyle factors like diet and exercise play a huge role in heart disease, scientists are increasingly looking at our genetic code to understand why some people develop heart problems while others with similar habits do not.
A team of researchers in Saudi Arabia recently set out to investigate this genetic connection by focusing specifically on the Wnt signaling pathway. They wanted to see if tiny, natural variations in the genes that control this pathway could make a person more likely to develop cardiovascular disease. To do this, they gathered blood samples from 151 patients who had been diagnosed with heart disease and compared them with samples from 129 healthy individuals of the same age and background. The researchers looked at fifteen specific spots in the DNA, known as single-nucleotide polymorphisms, across eight different genes that are part of the Wnt system. These genes act as the switches, the wires, and the brakes of the signaling pathway. By comparing the genetic makeup of the sick group against the healthy group, the team hoped to find patterns that could explain who is at higher risk.
The study revealed that the relationship between these genes and heart disease is not simple or uniform; instead, it depends heavily on a person's age and gender. The researchers found that certain genetic variations acted as protective shields, while others acted as risk factors, but these effects changed depending on who was being looked at. For instance, two variations in a gene called APC were found to lower the risk of heart disease, but this protection was most noticeable in men and in people under the age of 58. In contrast, variations in a gene called AXIN2 appeared to increase the risk of heart disease, but the impact was different for men and women. One specific variation in AXIN2 made men significantly more likely to develop heart disease, while another variation in the same gene made people over the age of 58 more susceptible, regardless of gender.
The investigation also uncovered that the Wnt pathway involves both internal regulators and external modulators, and variations in both types of genes mattered. A gene called DKK4, which acts as an external modulator, showed a strong link to increased risk, particularly in men and older individuals. Similarly, a gene called SFRP3 showed a split personality: one variation in this gene increased the risk for older people, while another variation in the same gene seemed to offer protection. The researchers also examined a gene called LRP6, which helps the cell receive the Wnt signal. They found that one variation in this gene increased the risk for women, while a different variation in the same gene actually protected men. Interestingly, the study found no significant link between heart disease and variations in three other genes they tested, suggesting that not every part of the Wnt pathway contributes equally to heart risk in this population.
These findings suggest that the genetic architecture of heart disease is a complex puzzle where the pieces fit together differently for different people. The study indicates that specific genetic variants in the Wnt pathway can influence a person's susceptibility to cardiovascular disease, but only when viewed through the lens of their age and sex. The researchers emphasize that while these results are promising, they are based on a specific group of people and a relatively small number of participants. To confirm these discoveries and determine if these genetic markers can be used to predict heart disease risk in the wider world, larger studies involving more diverse populations are needed. Until then, this work serves as a crucial step in understanding how the intricate dance of our genes shapes the health of our hearts, highlighting that there is no single genetic cause for heart disease, but rather a collection of subtle, context-dependent factors.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.